More Queen Square Institute of Neurology news

Measures of a biomarker may help to improve diagnosis and predict future cognitive outcomes in Parkinson’s disease finds a large-scale study by UCL researchers.

Researchers in the UCL Queen Square Institute of Neurology find that the hippocampus sends signals to the visual cortex to predict what we are about to see.

Every year the Dean recognises the top postgraduate students, in terms of academic performance, from across the Faculty.

We're delighted to announce the election of Professor Schiavo (Professor of Cellular Neuroscience, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology) to Academia Europaea.

Dr Edwin Jabbari (UCL Queen Square Institute of Neurology) has received the prestigious fellowship to support his research in movement disorders.

The Reta Lila Weston Trust for Medical Research has awarded the UCL Queen Square Institute of Neurology more than £5 million for initiatives to prevent, diagnose and treat neurodegenerative diseases.

'Everything is Connected' is an exhibition celebrating neurological research and collaborations between artists, researchers and communities.

A powerful short film, from the International League Against Epilepsy (ILAE) Climate Change Commission, FutureNeuro Research Ireland Centre, RCSI University of Medicine & Health Sciences & UCL.

A study led by Dr Marc Aurel Busche (UK DRI at UCL, UCL Queen Square Institute of Neurology) sheds light on the earliest stage of Alzheimer’s.

UCL Queen Square Institute of Neurology held its third inaugural lecture evening of 2025, on 13th May 2025.

UCL Queen Square Institute of Neurology held its second inaugural lecture evening of 2025, on 8th May 2025.

We're delighted to announce that BrightFocus Foundation’s Alzheimer’s Disease Research program has awarded research grants to UCL scientists Professor Sir John Hardy, PhD, FRS.

Results of the MIROCALS (Modifying Immune Responses and Outcomes in ALS) clinical trial are published today in The Lancet.

We're delighted to announce that Dr Rob Wykes (Principal Research Fellow, Clinical & Experimental Epilepsy, UCL Queen Square Institute of Neurology) has received the Individual Researcher Prize.

A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer’s therapeutics to find out how the drugs bind to toxic amyloid beta protein to tackle the disease.